[1] Oliver T,Ciaudelli B,Cohen DA.Anticoagulation-Related Nephropathy:The Most Common Diagnosis You've Never Heard Of[J].Am J Med,2019,S0002-9343(19):30233-30235. [2] Brodsky SV,Nadasdy T,Rovin BH,et a1.Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate[J].Kidney Int,2011,80(2):181-189. [3] Logan IR,Sheerin NS.Anticoagulation and kidney injury:rare observation or common problem?[J].J Nephrol,2013,26(4):603-605. [4] Niu XF.The combination of voriconazole for injection and warfarin sodium tablets resulted in increasing the international standardized ratio:a case report[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2017,14(08):500-501,503. [5] Limdi NA,Beasley TM,Baird MF,et a1.Kidney function influences warfarin responsiveness and hemorrhagic complications[J].J Am Soc Nephrol,2009,20(4):912-921. [6] Wang W,Tao Y.Warfarin related nephropathy[J].West China Medical Journal(华西医学),2015,30(7):1365-1368. [7] Di Maso V,Carraro M,Bevilacqua E,et a1.Warfarin-related nephropathy:possible role for the warfarin pharmacogenetic profile[J].Clin Kidney J,2014,7(6):605-608. [8] Ryan M,Ware K,Qamri Z,et a1.Warfarin-related nephropathy is the tip of the iceberg:direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats[J].Nephrol Dial Transplant,2014,29(12):2228-2234. [9] Beazley KE,Eghtesad S,Nurminskaya MV.Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein[J].J Biol Chem,2013,288(4):2632-2640. [10] Motoko Yanagita,Yoshikazu Ishimoto,Hidenori Arai,et a1.Essential role of Gas6 for glomerular injury in nephrotoxic nephritis[J].J Clin Invest,2002,110(2):239-246. [11] Lai QQ,Gan H.Research Progress of Hua Falin Associated Nephropathy[J].Medica ) Medical Information(医学信息),2013(28):728-729. [12] Swapnil Patel,Mohammad A.Hossain,et a1.Dabigatran-Induced Acute Interstitial Nephritis:An Important Complication of Newer Oral Anticoagulation Agents[J].J Clin Med Res,2018,10(10):791-794. [13] Ware K,Qamri Z,Ozcan A,et a1.N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy[J].Am J Physiol Renal Physiol,2013,304(12):F1421-1427. [14] Chan YH,Yeh YH,Hsieh MY,et a1.The risk of acute kidney injury in Asians treated with apixaban,rivaroxaban,dabigatran,or warfarin for non-valvular atrial fibrillation:A nationwide cohort study in Taiwan[J].Int J Cardiol,2018(265):83-89. [15] Wheeler DS,Giugliano RP,Rangaswami J,et a1.Anticoagulation-related nephropathy[J].J Thromb Haemost,2016,14(3):461-467. [16] Zhang S,Yang YM,Huang CX,et a1.Guideline of stroke prevention in Chinese patients with atrial fibrillation(2017)[J].Chin J Cardiac Arrhyth(中华心律失常学杂志),2018,22(1):17-30. [17] Romualdi E,Micieli E,Ageno W,et al.Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage.A systematic review[J].Thromb Haemost,2009,101(2):290-297. [18] Woo KT,Lee GS,Foo MW,et al.Warfarin-related nephropathy in patients with chronic kidney disease[J].Kidney Int.2012,82(1):113-114. |